You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Life Science seminar 2024
Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies take on their late-stage pipeline.
We are proud to present: Ascelia Pharma, Gubra, BioPorto, Pharma Equity Group and ExpreS2ion Biotechnologies.
Agenda
09.35-09.55 - Introduction
10.00-10.25 - Ascelia Pharma
10.30-10.55 - Gubra
11.00-11.25 - BioPorto
11.30-11.55 - Pharma Equity Group
12.00-12.25 - ExpreS2ion Biotechnologies
Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma, Gubra, BioPorto, Pharma Equity Group and ExpreS2ion Biotechnologies. for a Digital IR/corporate visibility agreement./Mie Halse 14.05.2024 at 13.33.